Oseltamivir phos 75 MG capsule UD 10S
Ended Awarded Last action
- Contract number
- SPE2DR26F7MQN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,996
Award facts
- Contract value 100% obligated
- $2,995.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,995.68 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of December 4, 2025. The award was issued on December 3, 2025, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a broad range of medications and medical supplies to support military and veteran healthcare systems. The company holds significant federal contracting experience across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency and its Medical Supply Chain. This antiviral medication order represents a routine component of the company's extensive portfolio of pharmaceutical deliveries supporting Department of Defense healthcare requirements. The DLA Troop Support is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards anticipated, underscoring the strategic importance of reliable pharmaceutical supply chains for military operations.
Quick answers
Who was awarded contract SPE2DR26F7MQN?
SPE2DR26F7MQN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F7MQN worth?
The government has obligated $2,996 on SPE2DR26F7MQN.
Is contract SPE2DR26F7MQN an order under another contract?
Yes. SPE2DR26F7MQN is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MQN competed?
The extent of competition for SPE2DR26F7MQN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award